New Drug For Parkinson's Disease Proves Effective, S...( 0percent compared to patients taking a...)

New Drug For Parkinson's Disease Proves Effective, Study Finds

0 percent compared to patients taking a placebo. "Patients with worse symptoms saw even bigger gains, suggesting that the drug may be useful in treating mild to moderate cases of Parkinson's disease," Dr. Kieburtz says.

Physicians have begun a two-year study of 300 patients funded by Pharmacia & Upjohn and led by the University of Rochester to study the long-term effects of the drug.

The research was supported by Pharmacia & Upjohn, which supplied the drug, as well as the National Institutes of Health and the National Parkinson Foundation. Dr. Kieburtz's collaborators in the study included Ira Shoulson, M.D., and Michael McDermott, Ph.D., at the University of Rochester, Stanley Fahn, M.D., of Columbia University, Anthony Lang, M.D., of The Toronto Hospital, Warren Olanow, M.D., of Mt. Sinai Hospital, John Penney, M.D., of Massachusetts General Hospital, and G. Frederick Wooten, M.D., of the University of Virginia Health Sciences Center.

At Rochester the study was coordinated through the Department of Neurology's Clinical Trials Coordination Center and the Division of Experimental Therapeutics, where physicians are trained to design and interpret studies of potential new treatments to neurodegenerative diseases.

'"/>

Contact: Steve Bradt
sbradt@admin.rochester.edu
716-273-4726
University of Rochester
8-Jul-1997

Page: 1 2 3
Related medicine news :

1. Rasagiline reduces disability for patients with advanced Parkinsons disease
2. LRRK2 gene mutation causes Parkinsons disease in several families
3. Physical activity linked to protection from Parkinsons disease
4. PCBs, fungicide open brain cells to Parkinsons assault
5. New study in NEJM suggests levodopa may slow progression of Parkinsons disease
6. Two-fisted assault on dopamine transport system may be foundation of Parkinsons disease
7. Antibiotic rifampicin shows promise for fighting Parkinsons disease in lab tests
8. University seeks recruits for Parkinsons Disease study
9. Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinsons to pain
10. Exercising limbs protects brain cells affected by Parkinsons, study in rodents shows
11. Parkinsons patients get bilateral benefits with unilateral brain stim

Post Your Comments:

(Date:11/25/2009)...RNewswire-FirstCall/-- OnyxPharmaceuticals,Inc.(N...woinvestoreventsinDecember: ,, ASHBriefing ..., Principalinvestigatorswilldiscussdatapresentat...rymultiplemyeloma,asfeaturedatthe51stAmericanSocie...Orleans,LA.Theteleconferencewillbeginat9:00a.m.CT/...

(Date:11/25/2009)...Newswire/--Thanksgivingmealswillbedeliveredtoappro...areathankstoFaithInAction/VolunteerActionforAging,...nofSCANHealthPlan.Formorethan17yearstheseorganizat...hanksgivingmealstoseniorsinneedinLongBeach,Lakewoo...gcities. ,, "Ourwarmholidaymealsaredeliveredtop...

(Date:11/25/2009)...wire/--TheBayAreaAirQualityManagementDistrictisiss... Alert forThursday,November26,2009whichbansbu...bothindoorsandoutdoors. ,, "Cold,stillweatherwi...kBroadbent,executiveofficeroftheAirDistrict."We,re...ghborsandfellowcommunitymembersthisThanksgiving,an...

(Date:11/25/2009)...of a statistically significant survival benefit fr...n receptor (ER)-positive tumors had high levels of...pha S118-P), according to a brief communication pu...National Cancer Institute . , Approximately 50% ...reclinical studies have shown that ER-alpha S118-P...

(Date:11/25/2009)... short to draw definite conclusions, experts say,... -- In diabetic patients with blocked coronary art...es at one year whether patients undergo bypass sur...hers report. , Bypass surgery has been the stan... artery disease. However, less invasive approaches...

Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2 Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2 Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3

[0] Onyx Pharmaceuticals Announces December 2009 Investor Events [0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors [0] Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 [1] News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response [1] Stenting May Equal Bypass for Diabetic Heart Patients

(Date:11/25/2009)....25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Medica... CSKI ),a,leadingfullyintegratedpharmaceuticalcomp...hePeople,sRepublicofChina("PRC"),today,announcedth...utefor,theControlofPharmaceuticalandBiologicalProd...sDiagnosticKitforHumanProstateSpecific,Antigen(Col...

(Date:11/25/2009)...v.25/PRNewswire/--AccordingtoMillenniumResearchGro...tintelligence,thenearly$3billionUSmarketfortraumaf...extfiveyearsdespitetherecenteconomicslowdown.MRG,s...ismarketwillremainhighlydynamicoverthenextfiveyear...eviouslyunderservedsegmentsofthetraumafixationmark...

(Date:11/25/2009)...andsandJOHANNESBURG,November25/PRNewswire/--,iThem...announcedtoday,thattheyhavesignedacollaborativeagr..., Pyxis,sworldclasscomputationalchemistryandleadd...edivisiontoprovidemedicinaland,syntheticchemistrys...nalclientnetwork.iThembaPharmaceuticalsandPyxisDis...

Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2 China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3 US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2 US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3 iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2 Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 1 Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 2 Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 3 Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 4 AMD LASERS Announces the Addition of Bart Waclawik New Chief Operating Officer 6290 1 AMD LASERS Announces the Addition of Bart Waclawik New Chief Operating Officer 6290 2 Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 1 Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 2 Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 3 Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 4

[0] China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits [0] US Trauma Fixation Device Market Not Seeing Signs of Slowdown [0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering

Other News:

...ay use light to tell whether breast cancer has spr...ws briefing at the 3rd European Breast Cancer Conf...Optical detection of breast cancer is an exciting ...ersity College London (UCL) in the UK. Mr Lee is p...

...tts General Hospital (MGH) have discovered powerfu...lonal antibody used to fight certain forms of brea...eceptor HER2 on breast cancer cells and is used to...HER2, a more aggressive form of cancer. The new d...

... may interfere with the cascade of reactions that ... heart-attack patients and may help prevent clot f... of heart attack and stroke, new research by Unive...e researchers have demonstrated that an infusion o...

...loping the use of a computer touch screen to recor...cts of their treatments and their quality of life,...elona hear on Friday 21 March. ......Professor Rob...ute, Singleton Hospital, Swansea, UK, reported tha...

health news:Detecting breast cancer spread by white light - groundbreaking technology 2 health news:MGH study finds herceptin has additional antitumor qualities 2 health news:Study suggests insulin may have potential to prevent thrombosis leading to heart attack and stroke 2 health news:Keeping patients in touch with their lives and their treatments 2

Detecting breast cancer spread by white light - groundbreaking technology MGH study finds herceptin has additional antitumor qualities Study suggests insulin may have potential to prevent thrombosis leading to heart attack and stroke Keeping patients in touch with their lives and their treatments

...longed labour say that the experience will affect ...l found giving birth exciting.......Those are two ...published in the May issue of Journal of Clinical ...y Astrid Nystedt from Umea University, studied 84 ...

...innovative treatment for advanced head-and-neck ca... that about half of patients were still alive four...ology Group physicians announced results from thei...al Oncology annual meeting on May 14.......The tre...

...c medical oncologist and conducted by the North Ce...rtant new data about the effectiveness and safety ...y and a drug called trastuzumab (Herceptin)..........CTG study chair Edith Perez, M.D., these results c...

CHICAGO Adolescents with moderate to severe acne experienced a reduction rather than an increase in symptoms of depression while taking the medication isotretinoin, according to a study in the May i

health news:60 per cent of first-time mums say prolonged labour will affect them for life 2 health news:Chemo-radiation therapy treatment gives head-and-neck cancer a 1-2 punch 2 health news:Mayo researchers to announce new findings about promising early-stage breast cancer treatment 2 health news:Certain acne treatment does not increase symptoms of depression in adolescents 2

60 per cent of first-time mums say prolonged labour will affect them for life Chemo-radiation therapy treatment gives head-and-neck cancer a 1-2 punch Mayo researchers to announce new findings about promising early-stage breast cancer treatment Certain acne treatment does not increase symptoms of depression in adolescents

New Drug For Parkinson's Disease Proves Effective, S...( 0percent compared to patients taking a...),Health